Subscribe in seconds and receive Life Sciences Voice's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Life Sciences Voice: Lifescivoice - News and Insights of Life Sciences Industry
Is this your feed? Claim it!
Clinical trials are becoming increasingly complex as pharmaceutical companies evaluate more targeted therapies, recruit diverse patient populations, and generate larger volumes of clinical and real-world data. At the same time, sponsors face pressure to make development decisions faster without compromising statistical rigor, patient safety, or regula...
Electra Therapeutics plans to use proceeds from a proposed initial public offering to advance development of its lead drug candidate, ipsoprubart, which is being studied as a treatment for secondary hemophagocytic lymphohistiocytosis (sHLH), a rare and life-threatening inflammatory disorder.
The South San Francisco-based
Scholar Rock has received U.S. Food and Drug Administration approval for apitegromab, an injectable monoclonal antibody that will be marketed as Isembyld, for the treatment of spinal muscular atrophy (SMA). The approval marks the first FDA-cleared product for ...
A phase 2 study of Johnson & Johnson’s JNJ-5120 has failed to achieve its primary goal, raising fresh questions about the future of the depression treatment licensed from Contineum Therapeutics.
J&J secured global rights to the M1 receptor antag...
Artificial intelligence is becoming increasingly embedded in healthcare, but many AI applications still depend on centralized cloud infrastructure to process data and generate insights.
Edge AI offers a different approach.
Edge AI refers...